Eczema study tests longer breaks between injections

NCT ID NCT06004986

First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 24 times

Summary

This study looks at whether people with well-controlled eczema can safely extend the time between their dupilumab injections from every 2 weeks to every 3 or 4 weeks. About 216 adults with controlled atopic dermatitis will be randomly assigned to one of three dosing schedules. Researchers will track skin symptoms and quality of life to see if less frequent dosing works just as well.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Amsterdam University Medical Centers

    RECRUITING

    Amsterdam, North Holland, 1105 AZ, Netherlands

    Contact

  • Erasmus Medical Center

    NOT_YET_RECRUITING

    Rotterdam, South Holland, 3015 GD, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.